1. Home
  2. RNA

RNA

Avidity Biosciences Inc.

Logo Avidity Biosciences Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.

Founded: 2012 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 1.9B IPO Year: 2020
Target Price: $38.00 AVG Volume (30 days): 1.2M
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.91 EPS Growth: N/A
52 Week Low/High: $4.83 - $27.66 Next Earning Date: 05-07-2024
Revenue: $9,560,000 Revenue Growth: 3.64%
Revenue Growth (this year): 8.18% Revenue Growth (next year): -31.64%

Share on Social Networks: